Proton therapy for children — how it differs
When a radiation oncologist mentions proton therapy for your child, one of the first questions every parent asks is: how is this different from ordinary radiotherapy, and does that difference actually matter? This page explains — in plain language — how proton beam therapy works, why the physics of protons matter more for growing children than for adults, and when it is most likely to be considered.
- The Bragg peak — why protons stop at the tumour instead of passing through it
- Proton beam vs conventional radiation — the difference in healthy tissue exposure
- Which childhood cancers — the tumour locations where proton therapy is most discussed
- Coordinated decision-making — how the CION tumour board evaluates proton vs photon for each child
on Panel
Survival Rate*
Treated
(800+ reviews)
What is proton therapy — and why does it matter for a child?
Proton therapy for children is a form of radiation treatment that uses proton particles instead of the X-rays (photons) used in conventional radiotherapy. The underlying physics create a meaningful difference in where radiation energy is deposited inside the body — and for a child, that difference can matter a great deal.
How conventional radiation works
Standard radiation therapy delivers X-ray beams — streams of photon energy — into the body. As a photon beam travels through tissue, it deposits energy all along its path: entering through the skin, passing through the tumour, and continuing to deposit some energy in the healthy tissue beyond. Modern conventional radiotherapy has become very sophisticated at shaping beams from multiple angles to concentrate the dose at the tumour and reduce the exit dose — but some radiation to surrounding healthy tissue remains unavoidable.
How proton therapy is different — the Bragg peak
Proton beam therapy works on a different physical principle. When protons enter the body, they travel through tissue while losing energy slowly — then release the majority of their energy at a very specific depth called the Bragg peak. The radiation oncologist and treatment physicist calculate and control this depth precisely so it coincides with the tumour. Beyond the Bragg peak, the proton beam essentially stops. The result: the tumour receives its full planned dose, while the tissue immediately behind the tumour receives very little.
This does not mean no healthy tissue is exposed to protons at all — the beam still has to pass through the tissue between the skin surface and the tumour. But the difference lies in what happens on the other side. For a tumour located near a critical structure — the spinal cord, brain stem, optic nerve, or a developing growth plate — this exit-dose reduction can be clinically meaningful.
Energy deposited along the entire beam path — entering, through the tumour, and beyond it. Sophisticated multi-beam techniques reduce but cannot eliminate the dose beyond the target.
Very widely available. Highly effective for most childhood cancers. Decades of established protocols.
Most energy released at a controllable depth (Bragg peak). Minimal radiation deposited in tissue beyond the tumour. Physical principle limits the exit dose.
Less widely available. Most useful where the tumour is close to critical structures or where reducing exit dose has clear long-term benefit for the child.
Why healthy tissue sparing matters more in children
Children's bodies are still growing. Radiation reaching developing bone can affect how that bone grows — a small dose to the spine during treatment can cause uneven vertebral development and height differences over the following years. Radiation reaching the developing brain — especially in children under five — can affect the way cognitive abilities develop. Radiation to the heart or lungs during treatment for chest tumours carries a risk of cardiac and pulmonary effects that may not appear for ten or twenty years but are real and documented. This is the core reason why the proton vs radiation discussion is more clinically significant for children than for older adults: a child treated at five years old has potentially seven decades of life ahead. The goal is not just to control the cancer — it is to give the child the best possible long-term health after treatment ends.
For many childhood cancers and many tumour locations, conventional radiotherapy remains highly effective and the standard of care. Proton beam therapy is not automatically superior for every child — it is a tool that is particularly valuable in specific situations where the tumour's location makes reducing the exit dose medically important. Your child's radiation oncologist can compare the planned dose distributions for both options, which makes it possible to have a clear, evidence-grounded conversation about whether proton therapy offers a meaningful advantage in your child's specific case.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You deserve a clear answer — not just a recommendation
Our radiation oncologist can walk you through what the dose plans actually look like for your child's tumour — proton and photon side by side — so your family can make an informed decision.
Childhood cancers where proton therapy is most often discussed
Proton beam therapy is not appropriate for every childhood cancer — it is most relevant when the tumour's location means that reducing the radiation dose to nearby critical structures or growing tissues has clear clinical value. Below are the situations where radiation oncologists most commonly consider proton therapy as part of the treatment plan for a child.
Medulloblastoma, ependymoma & low-grade glioma
Brain tumours are among the most studied indications for paediatric proton therapy. Craniospinal irradiation — needed for medulloblastoma — exposes the entire spine to radiation. Proton craniospinal radiation can reduce the dose to the thorax and abdomen compared with conventional photon techniques, potentially lowering the risk of cardiac and pulmonary late effects. For ependymoma and low-grade glioma, the goal is precise local irradiation of the tumour bed while sparing adjacent brain structures. Your child's team will compare the proton and photon dose plans directly to determine which approach better protects the structures most important for your child's long-term development.
Craniopharyngioma, chordoma & chondrosarcoma
Tumours at the skull base sit among some of the most delicate and critical structures in the body — the optic nerves, the pituitary gland, the brain stem, the cranial nerves. Delivering a full radiation dose to these tumours while limiting dose to the adjacent structures is one of the most technically demanding challenges in radiation oncology. Proton beam therapy's ability to reduce the exit dose makes it a particularly compelling option for these locations, and it is widely used in major paediatric oncology centres for skull base chordoma and chondrosarcoma when surgery alone is insufficient. The evidence for proton therapy in craniopharyngioma continues to develop.
Spinal cord tumours & paraspinal sarcomas
Spinal tumours in children present a particular challenge: the spinal cord must receive enough radiation to control the tumour, but radiation to the developing vertebral bodies must be minimised to reduce the risk of growth asymmetry and scoliosis. Proton therapy can be targeted to the tumour while reducing dose to the adjacent vertebral growth plates. For paraspinal sarcomas — such as Ewing sarcoma arising in or near the spine — proton therapy can help spare the kidney, bowel, and reproductive organs from unnecessary radiation. This is especially relevant in adolescent patients where preserving fertility matters.
Orbital tumours, nasopharynx & rhabdomyosarcoma of the head
The head and neck region in children is anatomically complex and developmentally sensitive. Radiation to the orbit can affect eye development and vision; radiation to the developing facial skeleton can affect facial growth; radiation reaching the cochlea (inner ear) can cause hearing loss. For orbital tumours, rhabdomyosarcoma of the head and neck, and nasopharyngeal carcinoma, proton therapy may allow a full tumour dose while reducing radiation to the lens of the eye, the cochlea, the facial growth centres, and the major salivary glands — structures where radiation late effects are well documented in children and can substantially affect quality of life.
Hodgkin lymphoma & Ewing sarcoma of the chest
For children with mediastinal Hodgkin lymphoma requiring radiation to the chest, proton therapy can substantially reduce the radiation dose reaching the heart, lungs, and breast tissue compared with conventional photon techniques. This is clinically significant because cardiac late effects — including coronary artery disease and pericardial disease — and secondary breast cancer are established long-term concerns after chest radiation in young patients. Ewing sarcoma arising in the ribs or chest wall similarly involves radiation to structures where keeping heart and lung doses as low as possible has a meaningful long-term benefit. Whether proton therapy is indicated depends on the specific location, the field size required, and the child's age at treatment.
Hepatoblastoma, Wilms tumour & neuroblastoma
Selected cases of hepatoblastoma that require liver radiation, certain Wilms tumour scenarios involving the remaining kidney or the spine, and high-risk neuroblastoma requiring abdominal radiation may benefit from proton therapy. The primary goal in abdominal radiation is reducing dose to the bowel, kidneys, liver, and developing vertebral bodies. In young children with these tumours — who may be under two years old — the body is developing very rapidly and the tissues are particularly radiosensitive. The decision to use proton therapy for abdominal tumours is highly individual and based on detailed dosimetry planning comparing proton and photon distributions.
Is proton therapy relevant for your child's tumour?
Our radiation oncologist can review your child's scans and explain whether proton beam therapy offers a meaningful advantage — or whether conventional radiation achieves the same goals equally well.
What the proton therapy treatment process looks like for a child
Treatment planning comes first
Before any proton therapy begins, the team creates a detailed treatment plan. This involves a planning CT scan — sometimes with an MRI as well — to map the tumour and the surrounding structures in three dimensions. The radiation physicist and the oncologist use this map to calculate precisely where the Bragg peak should fall and how many beams from which angles will deliver the planned dose to the tumour while keeping doses to critical structures within safe limits. For children, the planning process also includes a comparison of the proton dose plan with an equivalent photon plan, so the team can demonstrate quantitatively what difference the proton approach makes for that specific child's anatomy.
Immobilisation and sedation for young children
Proton therapy is only effective if the child is completely still while the beam is being delivered. For older children and teenagers, this is achieved with a custom-fitted immobilisation device — a mould or mask made specifically for your child's body position. For very young children — typically under five — who cannot be expected to lie still reliably for the duration of a treatment session, daily general anaesthesia or sedation is usually required. While this adds complexity, paediatric anaesthesia teams experienced in radiation oncology manage this routinely. The anaesthesia is short and light, and most children recover quickly. The proton therapy team plans the immobilisation approach during the pre-treatment phase and discusses it with parents before treatment begins.
Daily treatment sessions and total duration
Proton therapy is typically delivered as a course of daily sessions — called fractions — five days a week, with weekends off for recovery. The total number of fractions depends on the cancer type, the dose needed, and the protocol being followed. Some courses run for four to six weeks; others are shorter. Each individual session is brief — the actual beam delivery takes only minutes, though set-up time and any anaesthesia preparation add to the total appointment length. Parents are encouraged to bring comfort items and ask questions at each visit. The radiation team and nursing staff are present throughout every session.
Side effects during treatment
The immediate side effects your child experiences during proton therapy are related to the area being treated, not to the type of radiation particle used. Fatigue is common across all forms of radiation. Skin changes, hair loss, nausea, or mucositis (mouth soreness) depend on the treatment site. The advantage of proton therapy over conventional radiation is expected mainly in reducing late effects — those that appear months or years after treatment ends — rather than in making the immediate treatment experience significantly easier. Your radiation oncologist will discuss what immediate side effects to watch for based on where your child's tumour is being treated and what the management plan for those side effects looks like.
Every CION radiation decision goes through the tumour board first
Proton or photon — the decision is never one doctor's call at CION. Our medical, surgical, and radiation oncologists review the plan together and explain their reasoning to you before treatment begins.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Your questions about proton therapy for children — answered
What is proton therapy and how is it different from conventional radiation?
Conventional radiation therapy (also called photon or X-ray radiation) deposits energy along the beam's entire path through the body — entering, passing through the tumour, and continuing beyond it. Proton beam therapy is different because protons release most of their energy at a specific depth inside the body — a phenomenon known as the Bragg peak — and deliver very little radiation beyond that point. In practical terms, this means the tumour can receive a full treatment dose while the healthy tissue on the far side of the tumour is largely spared. For a growing child, this difference in how energy is deposited can meaningfully reduce the radiation reaching nearby organs, the spine, the heart, or the developing brain, depending on where the tumour is.
Why does sparing healthy tissue matter more in children than in adults?
Children's bodies are still developing, which makes their tissues more sensitive to radiation than adult tissues. Radiation that reaches a growing bone can affect how it grows; radiation that reaches the developing brain — particularly in very young children — can affect cognitive development, learning, and memory years later. Radiation reaching the spine during treatment for certain brain or spinal tumours can affect vertebral growth, leading to height differences. Radiation to the heart or lungs during treatment for chest tumours can raise the risk of cardiac problems in adulthood. Because children have decades ahead of them after treatment, reducing the radiation dose to healthy tissue is not just a comfort issue — it is a long-term health issue. That is why the comparison between proton beam therapy and conventional radiation is particularly relevant for paediatric patients.
For which childhood cancers is proton therapy most commonly considered?
Proton beam therapy is most commonly discussed for childhood cancers where tumour location makes sparing nearby healthy tissue especially important. These include brain tumours (such as medulloblastoma, ependymoma, craniopharyngioma, and low-grade gliomas) where proximity to the brain stem, pituitary gland, or optic pathways raises concern about late effects; skull base tumours such as chordoma and chondrosarcoma; spinal tumours; certain head and neck tumours, including those of the nasal cavity or orbit; and selected cases of Hodgkin lymphoma, Ewing sarcoma, rhabdomyosarcoma, and hepatoblastoma. Whether proton therapy is appropriate depends on the individual tumour's location, size, and type — and on the evidence for benefit in that specific situation. Your child's radiation oncologist will explain whether it is relevant for your child's case.
Is proton therapy the same as the "proton beam" treatment I have read about?
Yes — proton therapy, proton beam therapy, and proton beam radiation therapy are all names for the same treatment. You may also hear it called proton radiotherapy. In all cases, the treatment uses a beam of proton particles (rather than the photon X-rays used in conventional radiotherapy) to target the tumour. Modern proton therapy centres use a technique called pencil-beam scanning or intensity-modulated proton therapy (IMPT), which can shape the proton beam very precisely around the tumour. If you read about "proton beam child cancer" treatment online, it refers to this same modality — the terminology used varies between different countries and sources.
How does the CION team decide whether proton therapy is right for my child?
At CION Cancer Clinics, every child's case is reviewed by a tumour board that includes medical oncologists, surgical oncologists, and radiation oncologists working together. When radiation is part of the treatment plan, the radiation oncologist evaluates both conventional and proton beam options based on the tumour type and location, the child's age and stage of development, the available evidence for proton versus photon radiation in that specific cancer, and practical factors including access and the child's ability to tolerate the treatment setup. The decision is always explained to the family in a 45-minute consultation so parents understand the reasoning and can ask questions before any treatment begins.
Does proton therapy have fewer side effects than conventional radiation for children?
The goal of proton therapy is to reduce the radiation dose to healthy tissue, which in theory should reduce certain late side effects compared with conventional radiation. The clinical evidence supporting this benefit is strongest for brain tumours and skull base tumours in children, where studies have shown reduced radiation dose to critical structures. However, the immediate side effects during treatment — such as fatigue, skin changes, and localised irritation — are broadly similar between proton and conventional radiation for a given tumour area. The meaningful difference is expected in late effects that appear years after treatment, such as effects on growth, cognition, hearing, and cardiac health. Whether the benefit is large or modest depends heavily on the specific tumour and its location. Your child's radiation oncologist will be able to give you a realistic picture for your child's situation. [MEDICAL SIGN-OFF: clinical comparison statements about late effects]
This page is for general informational purposes only and does not constitute medical advice. The information about proton beam therapy on this page reflects well-established principles of radiation oncology and paediatric oncology practice. Every child's cancer is different. Whether proton therapy is appropriate for your child's specific tumour depends on tumour type, location, stage, available treatment planning infrastructure, and the clinical judgement of your child's oncology team. Please consult a qualified paediatric radiation oncologist before making any treatment decisions. † Canonical trust numbers (17 oncologists, 35+ centres, 15,000+ patients, 4.8/5 rating) represent CION Cancer Clinics' overall programme and are verified internally.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.